Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmather Holdings Ltd
C.PHRM
Alternate Symbol(s):
PHRRF
psychedelics
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The...
Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PHRM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
(8)
•••
Itistoo
X
View Profile
View Bullboard History
Comment by
Itistoo
on Nov 06, 2021 6:01am
RE:Why the sudden drop after raising $10 million at 0.64
It is a bit confusing as it seems like most of the shares were bought much higher than the current price. I've taken this opportunity to average down and actually hope it stays here a little
...more
(53)
•••
Predator2018
X
View Profile
View Bullboard History
Post by
Predator2018
on Nov 05, 2021 2:04pm
Why the sudden drop after raising $10 million at 0.64
Two institutions bought the $10 million placement. They MUST be highly upset seeing the $10 mil drop to around $6 million in less than 1 month. Just wondering why the selloff!!
(1872)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Nov 03, 2021 8:00am
Research Collaboration Agreement with Revive Therapeutics
Focusing on partnership model for MicroDose-MN™ and MacroDose-MN™ patches to deliver psychedelics. Creating value and intellectual property protection for psychedelic programs
...more
(176)
•••
jdfm22
X
View Profile
View Bullboard History
Post by
jdfm22
on Nov 02, 2021 11:10am
PharmaTher CEO Buys More Shares on Open Market
Phabio Chianelli, CEO of PharmaTher bought more shares on October 29, 2021 on the open market. Always a good near-term sign for the share price. Cheers, jdfm22
...more
(0)
•••
Glenstock2016
X
View Profile
View Bullboard History
Post by
Glenstock2016
on Oct 28, 2021 11:09am
Got in yesterday but..
I will get out at a lost today... This stock is manipulated big time... If you have level 2 you can clearly see that they don't want this stock go to pass 0.48...
(36)
•••
GustheGreek
X
View Profile
View Bullboard History
Post by
GustheGreek
on Oct 27, 2021 1:45pm
She's sinking for no good reason.
Oh boy!!! I'm waiting to get back in this one when it settles down. Golden opportunity at this level.
(1872)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Oct 06, 2021 9:12am
Initiates Phase 2 Clinical Trial of Ketamine
TORONTO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, announced today that it
...more
(1872)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Sep 28, 2021 5:52pm
Closing of CAD$10 Million Private Placement
TORONTO, Sept. 28, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM)(OTCQB: PHRRF), a clinical-stage psychedelics biotech company, is pleased to announce
...more
(36)
•••
GustheGreek
X
View Profile
View Bullboard History
Comment by
GustheGreek
on Sep 27, 2021 9:18am
RE:PharmaTher To Raise $10.0 Million Via Institutional Investor
Buy people buy. Time to get back in this one. Easy double or triple at least very soon. BUY!!!
(147)
•••
fisysy
X
View Profile
View Bullboard History
Post by
fisysy
on Sep 24, 2021 2:02pm
Tremendous Healthy Potential of CBD
Sponsored Post: Cannabis seems to be meeting the potential demand in the international economy. Do you want to keep your eye on a great wave of green leaf in the market? This could be
...more
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Sep 24, 2021 8:30am
PharmaTher To Raise $10.0 Million Via Institutional Investor
PharmaTher Holdings this morning indicated that the company has secured a financing with institutional investors. The firm will be raising C$10.0 million via a financing conducted exclusively by H.C
...more
(36)
•••
GustheGreek
X
View Profile
View Bullboard History
Comment by
GustheGreek
on Aug 18, 2021 5:09pm
RE:Big news!!!
Stop loss was set at .82 so bye bye from me, over triple on this one, I'm happy. On to the next one. Glta.
(36)
•••
GustheGreek
X
View Profile
View Bullboard History
Post by
GustheGreek
on Aug 04, 2021 9:16am
Big news!!!
https://stockhouse.com/news/press-releases/2021/08/04/pharmather-granted-fda-orphan-drug-designation-for-ketamine-to-treat-amyotrophic
(12)
•••
clarkeb
X
View Profile
View Bullboard History
Post by
clarkeb
on Jul 26, 2021 6:03pm
H C Wainwright ... $5.00
H C Wainwright new target share price ... 26 Jul 2021.... $5.00 C
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share